Overexpression of cytoplasmic p21 is found in a variety of human cancers, including renal cell carcinoma, breast cancer, pancreatic cancer, testicular cancer, ovarian cancer, cervical cancer, squamous cell carcinomas and prostate cancer (47). This evidence concerns the gene CDKN1A and prostate carcinoma.